Relationship between interleukin-6 levels and ambulatory blood pressure in women with polycystic ovary syndrome
Objective To determine 24-hour ambulatory blood pressures (ABP) in patients with polycystic ovary syndrome (PCOS) and its relationship with interleukin-6 (IL-6). Design Prospective controlled study. Setting University hospital. Patient(s) Fifty-four PCOS patients. Intervention(s) Ambulatory blood pr...
Saved in:
Published in | Fertility and sterility Vol. 94; no. 4; pp. 1437 - 1443 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.09.2010
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objective To determine 24-hour ambulatory blood pressures (ABP) in patients with polycystic ovary syndrome (PCOS) and its relationship with interleukin-6 (IL-6). Design Prospective controlled study. Setting University hospital. Patient(s) Fifty-four PCOS patients. Intervention(s) Ambulatory blood pressure monitoring was conducted. Anthropometric, hormonal, metabolic, and inflammatory parameters, including plasma IL-6, C-reactive protein (CRP), fibrinogen, and nitric oxide (NO), were measured in each subject. Main Outcome Measure(s) Ambulatory blood pressure and plasma IL-6, CRP, fibrinogen, and NO. Result(s) Serum IL-6 levels of PCOS women in the highest systolic blood pressure (SBP) quartile were significantly higher than those of women in the lowest SBP quartile. The high serum IL-6 levels (serum IL-6 level ≥5.1 pg/mL) were associated with a higher probability of raised SBP (≥126 mm Hg), with an odds ratio of 2.2 (95% confidence interval 0.8–7.9). The systolic and diastolic (DBP) blood pressures were significantly related to serum IL-6 levels. The IL-6 levels were positively and significantly correlated with serum CRP levels. Interleukin-6 and CRP were negatively and significantly correlated with serum NO levels. Conlusion(s) The results suggest that raised plasma IL-6 levels may be related to ambulatory SBP and DBP in PCOS. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0015-0282 1556-5653 |
DOI: | 10.1016/j.fertnstert.2009.05.055 |